Endo International | ENDP - Cost Of Sales

Endo International Ordinary Shares reported $176.86M in Cost of Sales for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Cost Of Sales Change
Abbvie ABBV:US USD 4.17B 57M
Amarin AMRN:US USD 23.94M 11.87M
Ani Pharmaceuticals ANIP:US USD 36.33M 3.43M
Bristol Myers Squibb BMY:US USD 2.52B 167M
Coherus Biosciences CHRS:US USD 14.2M 21.03M
Eli Lilly And LLY:US USD 1.55B 31M
Endo International Ordinary Shares ENDP:US USD 176.86M 1.06M
Heron Therapeutics HRTX:US USD 14.72M 1.46M
Hikma Pharmaceutical HIK:LN USD 662M 72M
Horizon Pharma HZNP:US USD 240.79M 6.65M
JAZZ PHA JAZZ:US USD 167.36M 33.7M
Lannett LCI:US USD 66.62M 4.14M
Ligand Pharmaceuticals LGND:US USD 21.61M 7.46M
Merk MRK:US USD 3.36B 519M
Novartis NOVN:VX USD 3.84B 180M
Pacira Pharmaceuticals PCRX:US USD 61.92M 11.24M
Patterson Companies PDCO:US USD 1.26B 40.23M
Perrigo Ordinary Shares PRGO:US USD 772.7M 35.4M
Pfizer PFE:US USD 9.82B 3.73B
Phibro Animal Health PAHC:US USD 167.26M 3.39M
Revance Therapeutics RVNC:US USD 23.52M 12.78M
Supernus Pharmaceuticals SUPN:US USD 22.95M 2.92M
Takeda 4502:JP JPY 335.97B 30.53B
Teva Pharmaceutical TEVA:IT USD 1.78B 101M
Xeris Pharmaceuticals Inc XERS:US USD 6.29M 1.03M
Zoetis ZTS:US USD 651M 45M